Episurf Medical AB
STO:EPIS B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Episurf Medical AB
STO:EPIS B
|
SE |
|
Spring Real Estate Investment Trust
HKEX:1426
|
HK |
|
E
|
Embpar Participacoes SA
BOVESPA:EPAR3
|
BR |
|
AdEPT Technology Group PLC
LSE:ADT
|
UK |
Income Statement
Earnings Waterfall
Episurf Medical AB
Income Statement
Episurf Medical AB
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Revenue |
5
N/A
|
5
-9%
|
5
+8%
|
7
+32%
|
7
+1%
|
9
+20%
|
9
N/A
|
7
-19%
|
7
-1%
|
7
-3%
|
6
-3%
|
7
+8%
|
8
+13%
|
8
+4%
|
9
+16%
|
10
+10%
|
11
+8%
|
12
+9%
|
13
+6%
|
13
+2%
|
14
+8%
|
14
-2%
|
14
-1%
|
14
-1%
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(78)
|
(73)
|
(71)
|
(70)
|
(69)
|
(74)
|
(75)
|
(76)
|
(76)
|
(77)
|
(79)
|
(84)
|
(92)
|
(101)
|
(106)
|
(107)
|
(105)
|
(99)
|
(95)
|
(90)
|
(87)
|
(83)
|
(77)
|
(71)
|
|
| Selling, General & Administrative |
(29)
|
(27)
|
(28)
|
(28)
|
(29)
|
(31)
|
(32)
|
(34)
|
(36)
|
(39)
|
(40)
|
(40)
|
(43)
|
(48)
|
(49)
|
(47)
|
(43)
|
(36)
|
(35)
|
(37)
|
(37)
|
(39)
|
(36)
|
(31)
|
|
| Research & Development |
5
|
4
|
5
|
4
|
0
|
2
|
3
|
7
|
9
|
11
|
11
|
11
|
11
|
11
|
11
|
10
|
8
|
8
|
7
|
8
|
9
|
8
|
8
|
7
|
|
| Depreciation & Amortization |
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(8)
|
(7)
|
(8)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(8)
|
|
| Other Operating Expenses |
(47)
|
(42)
|
(40)
|
(39)
|
(33)
|
(40)
|
(40)
|
(42)
|
(40)
|
(42)
|
(42)
|
(48)
|
(52)
|
(57)
|
(60)
|
(61)
|
(61)
|
(60)
|
(58)
|
(52)
|
(50)
|
(43)
|
(40)
|
(39)
|
|
| Operating Income |
(73)
N/A
|
(68)
+7%
|
(66)
+3%
|
(63)
+4%
|
(62)
+2%
|
(66)
-6%
|
(66)
-1%
|
(69)
-5%
|
(69)
+1%
|
(71)
-3%
|
(72)
-2%
|
(77)
-7%
|
(84)
-9%
|
(93)
-11%
|
(96)
-3%
|
(97)
-1%
|
(94)
+3%
|
(86)
+8%
|
(82)
+5%
|
(77)
+6%
|
(73)
+6%
|
(69)
+5%
|
(63)
+9%
|
(58)
+8%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
2
|
3
|
2
|
3
|
1
|
1
|
1
|
1
|
(0)
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(73)
N/A
|
(69)
+6%
|
(67)
+3%
|
(64)
+4%
|
(63)
+2%
|
(66)
-5%
|
(67)
-1%
|
(69)
-4%
|
(69)
+1%
|
(70)
-2%
|
(72)
-3%
|
(77)
-7%
|
(84)
-9%
|
(93)
-11%
|
(96)
-3%
|
(95)
+2%
|
(92)
+3%
|
(85)
+8%
|
(80)
+6%
|
(76)
+5%
|
(72)
+6%
|
(68)
+5%
|
(62)
+8%
|
(58)
+7%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(73)
|
(69)
|
(67)
|
(64)
|
(63)
|
(66)
|
(67)
|
(69)
|
(69)
|
(70)
|
(72)
|
(77)
|
(84)
|
(94)
|
(97)
|
(95)
|
(92)
|
(85)
|
(80)
|
(76)
|
(72)
|
(68)
|
(62)
|
(58)
|
|
| Net Income (Common) |
(73)
N/A
|
(69)
+6%
|
(67)
+3%
|
(64)
+4%
|
(63)
+2%
|
(66)
-5%
|
(67)
-1%
|
(69)
-4%
|
(69)
+1%
|
(71)
-2%
|
(73)
-3%
|
(77)
-7%
|
(84)
-9%
|
(94)
-11%
|
(97)
-3%
|
(95)
+2%
|
(92)
+3%
|
(85)
+8%
|
(80)
+6%
|
(76)
+5%
|
(72)
+6%
|
(68)
+5%
|
(63)
+8%
|
(58)
+7%
|
|
| EPS (Diluted) |
-0.77
N/A
|
-0.39
+49%
|
-0.35
+10%
|
-0.39
-11%
|
-0.28
+28%
|
-0.29
-4%
|
-0.31
-7%
|
-0.24
+23%
|
-0.25
-4%
|
-0.28
-12%
|
-0.28
N/A
|
-0.15
+46%
|
-0.32
-113%
|
-0.35
-9%
|
-0.27
+23%
|
-0.19
+30%
|
-0.26
-37%
|
-0.24
+8%
|
-0.12
+50%
|
-0.1
+17%
|
-0.07
+30%
|
-0.08
-14%
|
-0.06
+25%
|
-0.06
N/A
|
|